No cART initiation |
Time since cART initiation, <3 months |
Time since cART initiation, ≥3 months | ||||
---|---|---|---|---|---|---|
Baseline characteristics | Cases, N |
HR | Cases, N | HR | Cases, N | HR |
CD4 count, cells/mm3 | ||||||
<50 | 21 | 1 | 15 | 0.92 (0.46–1.82) | 28 | 0.24 (0.09–0.65) |
50 – 100 | 13 | 1 | 8 | 0.67 (0.24–1.87) | 17 | 0.12 (0.04–0.39) |
100 – 200 | 30 | 1 | 12 | 0.62 (0.31–1.22) | 23 | 0.05 (0.01–0.19) |
200 – 350 | 81 | 1 | 16 | 0.73 (0.41–1.32) | 73 | 0.16 (0.09–0.29) |
≥350 | 259 | 1 | 44 | 1.76 (1.13–2.74) | 108 | 0.19 (0.12–0.29) |
HIV-RNA, log10 copies/mL | ||||||
<4 | 59 | 1 | 13 | 1.56 (0.73–3.33) | 39 | 0.31 (0.15–0.64) |
4–5 | 192 | 1 | 43 | 1.25 (0.78–2.01) | 115 | 0.13 (0.07–0.24) |
>5 | 153 | 1 | 39 | 0.96 (0.63–1.47) | 95 | 0.15 (0.09–0.24) |
Age, years | ||||||
< 35 | 151 | 1 | 34 | 1.2 (0.73–1.98) | 77 | 0.06 (0.03–0.1.2) |
35 – 50 | 198 | 1 | 49 | 0.9 (0.58–1.40) | 117 | 0.19 (0.11–0.33) |
≥50 | 55 | 1 | 12 | 2.1 (1.07–4.11) | 55 | 0.32 (0.15–0.69) |
Sex | ||||||
Male | 392 | 1 | 89 | 1.21 (0.84–1.74) | 226 | 0.14 (0.10–0.21) |
Female | 12 | 1 | 6 | 1.12 (0.67–1.88) | 23 | 0.12 (0.02–0.71) |